{
    "medicine_id": "4c24e2a0393aaa529f95a0d9ff5e667213788012",
    "platform_id": "DB11978",
    "metadata": {
        "name": "Daurismo 25 mg Tablet",
        "composition": "25 mg Glasdegib",
        "clinical_particulars": {
            "therapeutic_indications": "Glasdegib in combination with cytarabine is indicated for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are over 75 years old or that have co morbidities that preclude intensive induction chemotherapy L5080 Acute myeloid leukemia is characterized by abnormal production of myeloblasts red cells or platelets It is considered a cancer of blood and bone marrow and it is the most common type of acute leukemia in adults L4832",
            "contraindications": {
                "disease": "Glasdegib is not mutagenic in bacterial reverse mutation assays and is not clastogenic in _in vitro_ chromosome aberration assays In fertility studies glasdegib has the potential to impair reproductive function in males due to the production of testicular changes such as hypospermatogenesis FDA label Overdose by glasdegib starts at 640 mg day and shows to present nausea vomiting dehydration fatigue and dizziness In case of overdose symptomatic treatment and ECG monitoring are advised FDA label The reported oral LD50 in rat of gladegib administered in triacetin is reported to be of 3000 mg kg F2971",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In preclinical studies glasdegib achieved a significant reduction in leukemic stem cell burden in xenograft models and a reduction in cell population expressing leukemic stem cell markers A173857 In clinical trials glasdegib demonstrated a marked downregulation of more than 80 of the expression of glioma associated transcriptional regulator GL11 in skin In this same study 8 of the studied individuals with acute myeloid leukemia achieved morphological complete remission while 31 achieved stable disease state A173857 The latest clinical trial proved glasdegib to generate an overall survival of 8 3 months which was almost double to what has been observed in patients under low dose cytarabine treatment As well there have been reports of dose dependent QTc prolongation in patients administered with glasdegib L5080",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Afatinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Colchicine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Ledipasvir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The serum concentration of Naloxegol can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Pazopanib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The serum concentration of Prucalopride can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Everolimus can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Rifaximin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The excretion of Vincristine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The serum concentration of Doxorubicin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Glasdegib can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Methadone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Clozapine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Primaquine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Propafenone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Flecainide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Eperisone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Melperone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Entinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 101 is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Simendan is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Sultopride is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Otilonium is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Citalopram is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Clemastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Quinine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Sotalol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Toremifene is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Imatinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Cocaine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Procainamide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Escitalopram is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Domperidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Bepridil is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Temafloxacin is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Asenapine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Artemether is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Cisapride is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Glasdegib can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Glasdegib can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Glasdegib can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Loratadine"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Glasdegib can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Glasdegib may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Glasdegib can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Pravastatin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Buprenorphine may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01051",
                        "description": "Novobiocin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "Hesperetin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02115",
                        "description": "Daidzin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03467",
                        "description": "Naringenin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "Quercetin may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "Elacridar may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "Dovitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "Vismodegib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "Palbociclib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "Olaparib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "Daclatasvir may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "Dasabuvir may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "Rolapitant may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "Paritaprevir may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "Alectinib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "Velpatasvir may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Glasdegib may decrease the excretion rate of Folic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "Glasdegib may decrease the excretion rate of Cladribine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Glasdegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Glasdegib may decrease the excretion rate of Allopurinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Glasdegib may decrease the excretion rate of Prazosin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Glasdegib may decrease the excretion rate of Celecoxib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "Glasdegib may decrease the excretion rate of Zidovudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Glasdegib may decrease the excretion rate of Methotrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Glasdegib may decrease the excretion rate of Clofarabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Glasdegib may decrease the excretion rate of Sumatriptan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Glasdegib may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Glasdegib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Glasdegib may decrease the excretion rate of Lamivudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "Glasdegib may decrease the excretion rate of Riluzole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "Glasdegib may decrease the excretion rate of Irinotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Glasdegib may decrease the excretion rate of Glyburide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "Glasdegib may decrease the excretion rate of Tegaserod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "Glasdegib may decrease the excretion rate of Leflunomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Glasdegib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03496",
                        "description": "Glasdegib may decrease the excretion rate of Alvocidib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04690",
                        "description": "Glasdegib may decrease the excretion rate of Camptothecin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "Glasdegib may decrease the excretion rate of Apixaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "Glasdegib may decrease the excretion rate of Pitavastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Glasdegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Glasdegib may decrease the excretion rate of Riociguat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Glasdegib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "Glasdegib may decrease the excretion rate of Fimasartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "Glasdegib may decrease the excretion rate of Ombitasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Glasdegib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Glasdegib may decrease the excretion rate of Revefenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "Glasdegib may decrease the excretion rate of Duvelisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "Glasdegib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "Glasdegib may decrease the excretion rate of Rucaparib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "Glasdegib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "Glasdegib may decrease the excretion rate of Pibrentasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "Glasdegib may decrease the excretion rate of Glecaprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "Avatrombopag may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "Medical Cannabis may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "Nabiximols may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "Glasdegib may decrease the excretion rate of Donepezil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "Fedratinib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "Caffeine may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "Glasdegib may decrease the excretion rate of Tazemetostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Gefitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "Beclomethasone dipropionate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "Dexamethasone may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Rilpivirine may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "Glasdegib may decrease the excretion rate of Cerivastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Glasdegib may decrease the excretion rate of Teniposide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "Glasdegib may decrease the excretion rate of Raloxifene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "Glasdegib may decrease the excretion rate of Ivermectin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Glasdegib may decrease the excretion rate of Testosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Glasdegib may decrease the excretion rate of Daunorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Glasdegib may decrease the excretion rate of Ezetimibe which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "Glasdegib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Glasdegib may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Glasdegib may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Glasdegib may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Glasdegib may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Estradiol dienanthate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "Glasdegib may decrease the excretion rate of Selumetinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Glasdegib may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "Glasdegib may decrease the excretion rate of Ripretinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Tenofovir disoproxil"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Tezacaftor"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Morphine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Clobazam can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Mannitol can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Clomifene can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Sitagliptin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Belinostat can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Prednisolone phosphate can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04540",
                        "description": "Cholesterol may increase the excretion rate of Glasdegib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Dactinomycin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Cobimetinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The serum concentration of Dasatinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Glasdegib can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Pyrimethamine"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Montelukast"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Liotrix"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Licofelone"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB11632",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Opicapone"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Glasdegib can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Glasdegib can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Glasdegib can be increased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Glasdegib can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Glasdegib can be increased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Glasdegib can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Glasdegib can be increased when combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Glasdegib can be increased when combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Glasdegib can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Glasdegib can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Glasdegib can be increased when combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Glasdegib can be increased when combined with Hydrocortisone phosphate"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Dapsone"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00799",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Tazarotene"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Repaglinide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Mestranol"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB06510",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Muraglitazar"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of Glasdegib can be decreased when combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The metabolism of Balaglitazone can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The metabolism of S Warfarin can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB08502",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Capravirine"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Theophylline"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Azelastine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Anastrozole"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Tegafur"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The excretion of Baricitinib can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The excretion of Metformin can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The excretion of Cephalexin can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The excretion of Acyclovir can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The excretion of Ganciclovir can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The excretion of Cefradine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The excretion of Estrone sulfate can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "The excretion of N methylnicotinamide can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12377",
                        "description": "The excretion of Relebactam can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The excretion of Solriamfetol can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "The excretion of Emtricitabine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The excretion of Cimetidine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The excretion of Nadolol can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00536",
                        "description": "The excretion of Guanidine can be decreased when combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB13609",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Umifenovir"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Glasdegib can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Glasdegib can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Glasdegib can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Glasdegib can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Glasdegib can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Glasdegib can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Glasdegib can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Glasdegib can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Glasdegib can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Glasdegib can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Glasdegib can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Glasdegib can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Glasdegib can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Glasdegib can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Glasdegib can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Glasdegib may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Glasdegib may decrease the excretion rate of Metildigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Glasdegib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The serum concentration of Alpelisib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Glasdegib may increase the QTc prolonging activities of Lefamulin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Glasdegib may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Glasdegib can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11644",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Tafamidis"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "Glasdegib may decrease the excretion rate of Ozanimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Glasdegib may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Glasdegib can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Pralsetinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Glasdegib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}